Drugs / RO7051790
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02913443 | Dec 2016 → Oct 2017 | small cell lung carcinoma | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO7051790 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02913443 ↗ |
| Route | Oral | “RO7051790 will be given orally.” NCT02913443 ↗ |